These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats. Feldon J; Weiner I Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324 [TBL] [Abstract][Full Text] [Related]
4. Administration of corticosterone after the first downshift trial enhances consummatory successive negative contrast. Bentosela M; Ruetti E; Muzio RN; Mustaca AE; Papini MR Behav Neurosci; 2006 Apr; 120(2):371-6. PubMed ID: 16719701 [TBL] [Abstract][Full Text] [Related]
6. Anti-anxiety self-medication in rats: oral consumption of chlordiazepoxide and ethanol after reward devaluation. Manzo L; Donaire R; Sabariego M; Papini MR; Torres C Behav Brain Res; 2015 Feb; 278():90-7. PubMed ID: 25242284 [TBL] [Abstract][Full Text] [Related]
7. Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect. Gal G; Schiller D; Weiner I Behav Brain Res; 2005 Jul; 162(2):246-55. PubMed ID: 15970218 [TBL] [Abstract][Full Text] [Related]
8. Two profiles in the recovery of reward devaluation in rats: Latent class growth analysis. Annicchiarico I; Cuenya L Neurosci Lett; 2018 Sep; 684():104-108. PubMed ID: 29997060 [TBL] [Abstract][Full Text] [Related]
9. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Weiner I; Shadach E; Barkai R; Feldon J Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387 [TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. Rochford J; Sen AP; Quirion R J Pharmacol Exp Ther; 1996 Jun; 277(3):1267-75. PubMed ID: 8667187 [TBL] [Abstract][Full Text] [Related]
14. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action. Weiner I; Schiller D; Gaisler-Salomon I Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529 [TBL] [Abstract][Full Text] [Related]
16. Reward shifts in forced-choice and free-choice autoshaping with rats. Conrad SE; Papini MR J Exp Psychol Anim Learn Cogn; 2018 Oct; 44(4):422-440. PubMed ID: 30407066 [TBL] [Abstract][Full Text] [Related]
17. Disruption of latent inhibition by acute administration of low doses of amphetamine. Weiner I; Lubow RE; Feldon J Pharmacol Biochem Behav; 1988 Aug; 30(4):871-8. PubMed ID: 3227035 [TBL] [Abstract][Full Text] [Related]
18. Function of the centromedial amygdala in reward devaluation and open-field activity. Kawasaki K; Glueck AC; Annicchiarico I; Papini MR Neuroscience; 2015 Sep; 303():73-81. PubMed ID: 26141844 [TBL] [Abstract][Full Text] [Related]
19. Effect of the NMDA antagonist MK-801 on latent inhibition of fear conditioning. Traverso LM; Ruiz G; De la Casa LG Pharmacol Biochem Behav; 2012 Oct; 102(4):488-94. PubMed ID: 22735831 [TBL] [Abstract][Full Text] [Related]
20. Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift. Schiller D; Weiner I Behav Brain Res; 2005 Aug; 163(1):115-21. PubMed ID: 15921766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]